Evaluation of biomedical research in Saudi Arabia.

Saudi Med J

Internal Medicine Department, Al Hada Hospital, PO Box 11135, Taif 21944, Kingdom of Saudi Arabia. Tel. +966 501737212. E-mail:

Published: September 2013

Objective: To evaluate the quality and quantity of biomedical studies published in the Kingdom of Saudi Arabia (KSA) between 2010 and 2011.

Methods: This study was conducted on January 2013 at the Internal Medicine Department, Taif University, Taif, KSA. An online search was conducted on PubMed to collect the articles published from KSA using the country name (Saudi Arabia) as a keyword. The search was limited to studies published in the period of 2 years from January 2010 to December 2011. The year 2012 was not included to give at least one year for citation. The total number of studies during the stated period was compared with those published from other countries in the same period, and adjusted per population size. Impact factor and number of citations were used to assess the quality of the studies.

Results: A total of 1905 published articles/studies were from KSA in the said period. Australia had the maximum number of studies (100%) published per million population (1258.571+). The KSA had 72.71 articles per million population, and was ranked 16th among the other countries. Most of the articles (65.3%) were published from Riyadh followed by Jeddah (13.3%), and most of them were from the fields of Community Medicine (15.5%), Pathology (13.7%), Medicine (13.2%), and Surgery (13.1%). King Faisal Specialist Hospital in Riyadh had the highest impact factor with a mean of 2.74 +/- 3.45.

Conclusion: The Kingdom of Saudi Arabia is lagging behind in biomedical research. While King Faisal Specialist Hospital and Research Centre appears to be doing better than other institutions in biomedical research, there is an urgent need for greater investment in biomedical research in the kingdom.

Download full-text PDF

Source

Publication Analysis

Top Keywords

saudi arabia
16
studies published
8
kingdom saudi
8
number studies
8
impact factor
8
king faisal
8
faisal specialist
8
specialist hospital
8
published
7
ksa
5

Similar Publications

Acute kidney injury (AKI) is a frequent clinical complication lacking early diagnostic tests and effective treatments. Novel biomarkers have shown promise for enabling earlier detection, risk stratification, and guiding management of AKI. We conducted a systematic review to synthesize evidence on the efficacy of novel biomarkers for AKI detection and management.

View Article and Find Full Text PDF

Aim: This study aimed to identify the most commonly used tools by recent pharmacy graduates who successfully passed the Saudi Pharmacists Licensure Examination (SPLE). It also sought to evaluate which tools were perceived as the most useful and representative of the exam content, while considering their monetary value and offering recommendations for future candidates.

Methods: A cross-sectional design was used, involving licensed pharmacists who graduated in 2019 or later and had successfully passed the SPLE.

View Article and Find Full Text PDF

Nephrotoxic effect of cypermethrin ameliorated by nanocurcumin through antioxidative mechanism.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, 45142, Jazan, Saudi Arabia.

Cypermethrin is a pyrethroid showing nephrotoxicity by generating ROS-impaired oxidative stress and changes in inflammatory and apoptotic markers. The harmful consequences are intended to be mitigated by the imbalance between oxidants and antioxidants. The anti-inflammatory and antioxidant possessions of nanocurcumin (NC) with improved bioavailability ameliorate Cyp toxicity in rat kidneys.

View Article and Find Full Text PDF

Exaggerated neuronal excitation by glutamate is a well-known cause of excitotoxicity, a key factor in numerous neurodegenerative disorders. This study examined the neurotoxic effect of monosodium glutamate (MSG) in the brain cortex of rats and focused on assessing the potential neuroprotective effects of omega-3 polyunsaturated fatty acids (ω-3 PUFAs). Four groups of adult male rats (n = 10) were assigned as follows; normal control, ω-3 PUFAs (400 mg/kg) alone, MSG (4 mg/g) alone, and MSG plus ω-3 PUFAs (4 mg/g MSG plus 400 mg/kg ω-3 PUFAs).

View Article and Find Full Text PDF

Clinical practice guidelines (CPGs) and consensus-based recommendations (CBRs) require considerable effort, collaboration, and time-all within the constraints of finite resources. Professional societies, such as the International League Against Epilepsy (ILAE), must prioritize what topics and questions to address. Implementing evidence-based care remains a crucial challenge in clinical practice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!